👀 Ones to watch: Undervalued stocks to buy before they report Q3 earningsSee Undervalued Stocks

Zydus Lifesciences Ltd (ZYDU)

BSE
Currency in INR
1,058.00
-4.30(-0.40%)
Closed

ZYDU Comments

Buy for tgt of 1300
900 soon
Can someone help me analyze ZYDU?
If u already buy than keep trailing stop lose as per your risk.
zydus today 425 to 410 407
BuyPut stoploss 360
Below 300 soon
Sell this stock, do not hold it is a bad investment
450
target 450 March
buy CADILA sort term target 450 current price 378.70
Company name changes to Zydus Lifesciences Ltd... A new journey starts...
Target 🎯 500
Hopefully before March 31
something wrong but this share.Why no investors not attracted to this low priced fundamentally strong (as per data) stock?
good morning
something wrong but this share.Why no investors not attracted to this low priced fundamentally strong (as per data) stock?
550 level soon best pharma company
550 level soon best pharma company
520
Cadila appears to be headed for 410 levels, better to SELL and wait for results, ZyCovD vaccine seems to have been rejected by seers and the whole stock worth 1000 crore will expire soon
buy buy buy now is going to up for good news with getting a biggest contract(890Cr)
when?
Some stories in cadila why this fall
buy buy buy now is going to up for good news with getting a biggest contract(890Cr)
Buy for 730
Retailers it is going bearish
Selll sell
BUY BUY........CADILA.....BUY BUY8827666091
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.